About Champions Oncology

At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development lifecycle.

From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.

Champions Oncology was founded in 2007 with the goal of utilizing ground breaking, well-characterized Patient-derived Xenograft Models (PDX Models) to test targeted therapies to identify potential therapeutic options for cancer patients. With clinical sites and laboratories strategically localized around the globe, Champions Oncology is able to obtain samples, coordinate studies worldwide and in turn, generate therapeutic testing results faster. We pride ourselves on becoming part of your scientific team and focus on providing high-quality data to you, on time, every time.